Côd QR

Advanced Therapy Medicinal Products in type I diabetes mellitus: technological and regulatory challenges

Introduction: Type 1 Diabetes mellitus (T1DM) is an autoimmune disorder which arises from the destruction of insulin-producing pancreatic β-cells. Currently, Brazil’s advanced therapy medicinal products (ATMP), developed for clinical research and therapeutic purposes, take place in the so-called Cel...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia
Prif Awduron: Camila Leal-Lopes, Marluce da Cunha Mantovani, Mari Cleide Sogayar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Fundação Oswaldo Cruz 2018
Pynciau:
Mynediad Ar-lein:https://www.redalyc.org/articulo.oa?id=570563069006
https://www.redalyc.org/journal/5705/570563069006/
https://www.redalyc.org/journal/5705/570563069006/html/
https://www.redalyc.org/journal/5705/570563069006/570563069006.epub
https://www.redalyc.org/journal/5705/570563069006/movil
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!